ST, Debiotech deliver prototypes of disposable insulin nanopump

Debiotech and STMicroelectronics have delivered the first evaluation prototypes of a miniaturized insulin-delivery pump, According to the companies, the tiny device can be mounted on a disposable skin patch to provide continuous insulin infusion, enabling substantial advancements in the availability, treatment efficiency and the quality of life of diabetes patients. The Nanopump, which relies on microfluidic MEMS technology, has successfully passed initial testing stages. They are now ready to enter volume manufacturing.

"The success of the initial prototype tests has moved the revolutionary insulin Nanopump a step closer to market availability," said Benedetto Vigna, group VP and general manager of ST's MEMS and health care, RF transceivers and sensors division. "Working with our key partner Debiotech, we are readying a tiny piece of silicon that can make a huge difference to millions of diabetes patients around the world."

"This important milestone in the industrial production of the insulin Nanopump is a key achievement toward the successful launch of a new drug delivery device, combining the highest level of reliability and performance with an previously unmet level of convenience and safety for the patient," said Frederic Neftel, president and CEO of Debiotech. "The collaboration with ST has proven to be extremely efficient in time and achievements, allowing us to now concentrate on a future partnership with a leading medical device company who will be responsible to introduce the product on the market."